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Insulin resistance and lipid accumulation occur with aging, perhaps due to mitochondrial dysfunction. In this
issue of Cell Metabolism (Lee et al., 2010), older mice overexpressing mitochondrial targeted catalase had
reduced muscle mitochondrial oxidative damage, lower intramuscular lipid, and improved insulin sensitivity,
suggesting that enhanced ROS scavenging prevents age-associated mitochondrial impairments and insulin
resistance.Due to ‘‘population aging,’’ the largest
increase in new cases of type 2 diabetes
over the next 20 years is predicted to
occur in those aged R65 years. Why are
older individuals more susceptible to
developing diabetes? While there is no
definitive answer, several explanations
have been put forward: (1) a shift in body
composition, with reduced muscle mass
and increased body intra-abdominal fat
(visceral and hepatic) associated with
insulin resistance; (2) a shift toward
oxidizing carbohydrate with decreased
mobilization of lipid stores; and (3) an
increased risk for weight gain because of
less physical activity and reduced basal
metabolic rate. Recently, changes in
mitochondrial function with age have
been linked to metabolic risk factors for
developing type 2 diabetes. In this issue
(Lee et al., 2010), Dr. Shulman’s group
addresses the question of whether mito-
chondrial ‘‘dysfunction’’ in aging is
secondary to oxidative damage and
whether it is a cause or a consequence
of increased muscle lipid content and
muscle insulin resistance.
Shulman’s group previously showed
that healthy lean elderly individuals have
an 40% reduction in basal rates of
muscle mitochondrial oxidative phos-
phorylation activity, an 45% increase in
intramuscular lipid content, and a 40%
decrease in muscle insulin sensitivity
(Petersen et al., 2003). These results led
to the hypothesis that age-associated
reductions in muscle insulin sensitivity
may be secondary to reduced mitochon-
drial activity and increased intramyocellu-
lar lipid content. However, Petersen’s
elegant studies in humans could not
disentangle the cause-and-effect rela-tionships between oxidative damage,
reduced mitochondrial mass and/or effi-
ciency, muscle fat accumulation, and
insulin resistance present in aging.
Reactive oxygen species (ROS) are by-
products of normal cellular metabolism
that can cause cellular damage by oxida-
tion of lipids, proteins, and nucleic acids.
When oxidant production rate exceeds
the rate of antioxidant defense (SOD1,
SOD2, glutathione peroxidase, and cata-
lase), oxidative stress occurs, resulting
in irreversible cell injury and eventually
cellular death. Mitochondria are the pri-
mary producers of ROS and therefore
the main source of oxidant-induced
damage to the mitochondria and to the
cell. In fact, mitochondrial ROS produc-
tion accounts for up to 2%–4% of total
oxygen consumption (Barja, 1999).
To test the hypothesis that skeletal
muscle in older animals has fewer mito-
chondria that are less functional due
to greater oxidative damage, Lee and
colleagues conducted a series of well-
designed studies in mice using targeted
overexpression of human catalase
(MCAT) to the mitochondria (Lee et al.,
2010). Mitochondrial function was as-
sessedboth invitroand invivo inWTyoung
(3- to 6-month-old) and older (15- to
18-month-old) lean healthy mice versus
age-matched MCAT transgenic litter-
mates. Using state-of-the-art methods,
including 1H- and 31P-spectroscopy, hy-
perinsulinemic-euglycemic clamps, and a
host of assays on isolated skeletal muscle
tissue, the authors first showed that ad
libitum-fed older WT mice exhibited all
the ‘‘usual’’ deleterious metabolic impair-
ments associated with aging, including
increased oxidative damage, reducedCell Metabolism 12,mitochondrial content (30%) and func-
tion, increased intramuscular lipid content
(70%), and marked muscle insulin resis-
tance (35%) (Figure 1). Remarkably,
however, all of these age-related ailments
were prevented in the older mice overex-
pressing human catalase. The described
effect on mitochondrial health appeared
to be one of ‘‘rescue,’’ or prevention of
the usual physiological deficits that occur
with aging, rather than the biogenesis of
super muscle mitochondria. These results
support the hypothesis that mitochondrial
capacity/efficiency is reduced with age,
probably due to mitochondrial protein
oxidative damage, causing intramuscular
lipid accumulation and impaired insulin
action. The fact that this age-associated
cascade can be prevented by increasing
ROS scavenging may offer potential novel
therapy targets for improving insulin
sensitivity.
Despite the significant potential impact
of these findings on our understanding of
age-related insulin resistance, many
questions remain unanswered. Do these
transgenic mice live longer? In an earlier
study, mice with massive overexpression
(50 times higher activity) of human
catalase in cardiac and skeletal muscle
exhibited an impressive 5 and 5.5 month
increase in average and maximum life
span, respectively, with evidence of
reduced oxidative damage (Schriner
et al., 2005), supporting the free radical
theory of aging (Harman, 1956). This
theory, however, has been questioned
by the work of Dr. Arlan Richardson and
colleagues (Pe´rez et al., 2009), who found
that (1) overexpression of the major
cellular antioxidants is associated with
muscle dysfunction; (2) a basal level ofDecember 1, 2010 ª2010 Elsevier Inc. 557
Figure 1. Characteristics of Skeletal Muscle Mitochondria in Young and Older WT Mice and
in Older Mice with Overexpression of Human Catalase in Mitochondria
The electron transport system (ETS) of the inner mitochondrial membrane is the primary site of reactive
oxygen species (ROS) production and therefore the main source of oxidative stress (damage to proteins,
lipids, and DNA) in the mitochondria and in the cell. Free radical superoxide anions (O2
.) are generated
when electrons are donated from complexes I and III of the ETS to O2 instead of the appropriate ETS
subunit. 2%–4% of total oxygen consumption may go toward the production of ROS instead of energy
as ATP. Scavenging enzymes represent an important mitochondrial mechanism against oxidative stress
by neutralizing O2
. within the mitochondrial matrix (superoxide dismutase; MnSOD = SOD2) and
catalyzing the reduction of mitochondrial SOD2-generated H2O2 to nontoxic H2O in the mitochondria
and the cell (glutathione peroxidase and catalase). Mitochondria in young muscle (upper panel) are
numerous, efficient, and associated with less intramyocellular lipid (IMCL) and good insulin sensitivity.
With age (middle panel), muscle mitochondria become less numerous and seem to develop impaired
function associated with reduced oxidative capacity, likely causing an increase in IMCL and its metabo-
lites (DAG and ceramides). Together, these adverse changes result in impaired insulin sensitivity. By
overexpressing the human catalase in skeletal muscle mitochondria, Lee et al. (Lee et al., 2010) showed
that all of these impairments in aged muscle are reversed, including an improvement in insulin sensitivity
(bottom panel, red).
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ality; (3) despite evidence of decreased
oxidative stress, a 2-fold overexpression
of SOD2 does not alter life span or age-
related pathology; and (4) only one of
many genetic manipulations that
increased ROS had an effect on life span
(SOD1 knockout). Moreover, the longest-
living rodent (naked mole rat) produces
high levels of free radicals and has signif-
icant oxidative damage in protein, lipids,
and DNA (Buffenstein, 2005).
Some oxidative stress seems beneficial
to organisms in order to naturally upregu-
late a defensemechanism: the ‘‘hormetic’’
response (Masoro, 1998; Mattson, 2008).558 Cell Metabolism 12, December 1, 2010 ªOnly longer-term studies will tell us
whether the scavenging of excess mito-
chondrial ROS is beneficial for health
maintenance and life span. For example,
can ROS scavenging by catalase activa-
tion rescue the diabetes seen in db/db or
ob/ob mice? Surprisingly, in Lee’s study,
genomic DNA damage was not prevented
by catalase overexpression, indicating
that other age-related pathologies may
not be prevented. Whether the improved
scavenging of ROS had an impact on
mitophagy, fusion, or fission of mito-
chondria—besides mitochondrial bio-
genesis—was not investigated. Finally,
the authors did not test the effect of their2010 Elsevier Inc.genetic manipulation on exercise
tolerance.
What does the future hold for this
research? Can we create ROS-fighting
mitochondria in humans? Will this be the
key to antiaging strategies? Can we
simulate this exaggerated capacity to
quench mitochondrial-generated free
radicals through vigorous daily exercise
or other stress-inducing activities that
cause a hormetic response? Given the
relationship between increased ROS and
age-related inflammation, the current
studies may have an even broader
impact. For example, studies suggest
that damaged mitochondria are sensed
by macrophages via pattern recognition
receptors (PRRs) that lead to post-
translation processing of proinflammatory
cytokine IL-1b via an inflammasome-
dependent mechanism (Iyer et al., 2009).
Whether maintenance of functional mito-
chondrial content may lower age-related
inflammation remains an open question.REFERENCES
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